1. Interstitial lung disease risk with prostate cancer meds

   News item 30 November 2019 Pages: 1 - 1

2. Medsafe warns of vasculitis risk with Pradaxa

   News item 30 November 2019 Pages: 2 - 2

3. Sulfasalazine interference with ultraviolet absorbance in assays

   News item 30 November 2019 Pages: 3 - 3

4. Adverse events with high-intensity atorvastatin vs rosuvastatin

   Clinical study 30 November 2019 Pages: 4 - 4

5. Child-resistant unit-dose packaging reduces ED visits

   Clinical study 30 November 2019 Pages: 5 - 5

6. Drug-induced intracranial hypertension

   Clinical study 30 November 2019 Pages: 6 - 6

7. Long-term linagliptin safe in Japanese patients

   Clinical study 30 November 2019 Pages: 7 - 7

8. Serious adverse events with fluoropyrimidines in France

   Clinical study 30 November 2019 Pages: 8 - 8

9. Statins not associated with memory or cognitive decline

   Clinical study 30 November 2019 Pages: 9 - 9

10. Surveillance of 9v HPV vaccine safety

    Clinical study 30 November 2019 Pages: 10 - 10

11. Vaccine safety monitoring in Australia

    Media release 30 November 2019 Pages: 11 - 11

12. Vedolizumab not associated with increase in malignancies

    Clinical study 30 November 2019 Pages: 12 - 12

13. Aciclovir

    Case report 30 November 2019 Pages: 13 - 13

14. Acitretin

    Case report 30 November 2019 Pages: 14 - 14

15. Adalimumab

    Case report 30 November 2019 Pages: 15 - 15

16. Adalimumab

    Case report 30 November 2019 Pages: 16 - 16

17. Adalimumab

    Case report 30 November 2019 Pages: 17 - 17

18. Adalimumab/etanercept

    Case report 30 November 2019 Pages: 18 - 18

19. Adalimumab/infliximab

    Case report 30 November 2019 Pages: 19 - 19

20. Adalimumab/infliximab

    Case report 30 November 2019 Pages: 20 - 20

21. Adalimumab/vedolizumab

    Case report 30 November 2019 Pages: 21 - 21

22. Adenosine

    Case report 30 November 2019 Pages: 22 - 22

23. Afatinib/amrubicin

    Case report 30 November 2019 Pages: 23 - 23

24. Aflibercept

    Case report 30 November 2019 Pages: 24 - 24

25. Alemtuzumab

    Case report 30 November 2019 Pages: 25 - 25

26. Alendronic acid

    Case report 30 November 2019 Pages: 26 - 26

27. Alendronic acid

    Case report 30 November 2019 Pages: 27 - 27

28. Alendronic acid/prednisolone

    Case report 30 November 2019 Pages: 28 - 28

29. Amikacin/clarithromycin

    Case report 30 November 2019 Pages: 29 - 29

30. Amiodarone

    Case report 30 November 2019 Pages: 30 - 30

31. Amiodarone

    Case report 30 November 2019 Pages: 31 - 31

32. Amiodarone

    Case report 30 November 2019 Pages: 32 - 32

33. Amiodarone

    Case report 30 November 2019 Pages: 33 - 33

34. Amiodarone

    Case report 30 November 2019 Pages: 34 - 34

35. Amiodarone/hydrocortisone/levothyroxine sodium

    Case report 30 November 2019 Pages: 35 - 35

36. Amiodarone/thiamazole

    Case report 30 November 2019 Pages: 36 - 36

37. Amisulpride/risperidone/trihexyphenidyl

    Case report 30 November 2019 Pages: 37 - 37

38. Amitriptyline

    Case report 30 November 2019 Pages: 38 - 38

39. Amoxicillin

    Case report 30 November 2019 Pages: 39 - 39

40. Amphotericin-B/caspofungin/voriconazole

    Case report 30 November 2019 Pages: 40 - 40

41. Ampicillin

    Case report 30 November 2019 Pages: 41 - 41

42. Anabolic steroids/isotretinoin/testosterone

    Case report 30 November 2019 Pages: 42 - 42

43. Anti-inflammatories

    Case report 30 November 2019 Pages: 43 - 43

44. Antiarrhythmics

    Case report 30 November 2019 Pages: 44 - 44

45. Antibacterials

    Case report 30 November 2019 Pages: 45 - 45

46. Antihyperglycaemics/antihypertensives overdose

    Case report 30 November 2019 Pages: 46 - 46

47. Antihyperlipidaemics

    Case report 30 November 2019 Pages: 47 - 47

48. Antineoplastic

    Case report 30 November 2019 Pages: 48 - 48

49. Antineoplastics

    Case report 30 November 2019 Pages: 49 - 49

50. Antineoplastics

    Case report 30 November 2019 Pages: 50 - 50